Literature DB >> 16609682

Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population.

Y Li1, J A Staessen, L-H Li, P-J Gao, L Thijs, E Brand, S M Brand-Herrmann, D-L Zhu, J-G Wang.   

Abstract

Adrenomedullin (ADM) is a vasodilator and inhibits salt appetite. An A-to-G substitution at position -1984 in the promoter region of the ADM gene likely increases transcription. We therefore investigated this polymorphism in relation to blood pressure and urinary sodium in a Chinese population. We genotyped 427 Chinese enrolled in a family-based population study. We measured blood pressure by conventional sphygmomanometry and ambulatory monitoring. The frequencies of the ADM AA, AG, and GG genotypes were 50.6, 38.2, and 11.2%, respectively. In adjusted analyses, G allele carriers, compared to AA homozygotes, had significantly lower conventional (45.3 versus 48.5 mm Hg, P = 0.004) and 24-h (42.6 versus 44.3 mm Hg, P = 0.03) pulse pressures and urinary sodium excretion (143.8 versus 159.4 mmol/day, P = 0.03). In parents, but not offspring, both systolic pressure and pulse pressure were significantly (P<0.01) lower in G allele carriers. The genotypic difference in sodium excretion was consistent across the age range. In 68 informative offspring, transmission of the G allele was associated with lower urinary sodium excretion (effect size, 40.1 mmol/day, P = 0.01). In 81 healthy volunteers, the plasma ADM concentration was 15.2% higher in GG homozygotes than in sex- and age-matched AA subjects (11.4 versus 9.9 pmol/l, P = 0.10). In conclusion, in Chinese, the ADM -1984G allele is associated with lower sodium excretion and in older subjects also with lower systolic pressure and narrower pulse pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609682     DOI: 10.1038/sj.ki.5000213

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice.

Authors:  Manyu Li; Della Yee; Terry R Magnuson; Oliver Smithies; Kathleen M Caron
Journal:  J Clin Invest       Date:  2006-09-14       Impact factor: 14.808

Review 2.  Adrenomedullin and pregnancy: perspectives from animal models to humans.

Authors:  Patricia M Lenhart; Kathleen M Caron
Journal:  Trends Endocrinol Metab       Date:  2012-03-16       Impact factor: 12.015

Review 3.  Characteristics of hypertension in the Chinese population.

Authors:  Ji-Guang Wang; Yan Li
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 4.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

5.  Adrenomedullin signaling pathway polymorphisms and adverse pregnancy outcomes.

Authors:  Patricia M Lenhart; Thutrang Nguyen; Alison Wise; Kathleen M Caron; Amy H Herring; Alison M Stuebe
Journal:  Am J Perinatol       Date:  2013-06-24       Impact factor: 1.862

6.  Adrenomedullin and arterial stiffness: integrative approach combining monocyte ADM expression, plasma MR-Pro-ADM, and genome-wide association study.

Authors:  Farzin Beygui; Philipp S Wild; Tanja Zeller; Marine Germain; Raphaele Castagné; Karl J Lackner; Thomas Münzel; Gilles Montalescot; Gary F Mitchell; Germaine C Verwoert; Kirill V Tarasov; David-Alexandre Trégouët; François Cambien; Stefan Blankenberg; Laurence Tiret
Journal:  Circ Cardiovasc Genet       Date:  2014-07-22

Review 7.  Genetics of salt-sensitive hypertension.

Authors:  Pasquale Strazzullo; Ferruccio Galletti
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

8.  Associations of the adrenomedullin gene polymorphism with prehypertension and hypertension in Lithuanian children and adolescents: a cross-sectional study.

Authors:  Sandrita Simonyte; Renata Kuciene; Virginija Dulskiene; Vaiva Lesauskaite
Journal:  Sci Rep       Date:  2019-05-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.